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Reply to Whitfield
To the Editor:
Dr. John B. Whitfield (Whitfield 2002 [in this issue])
writes to call attention to the variation in alcohol-
dependence risk as a function of both the ADH1B
Arg47His polymorphism and specific populations. We
do not disagree with his result: our study (Osier et al.
2002) involved, primarily, normal individuals from mul-
tiple populations and showed considerable variation in
allele frequencies at that site among the populations. In
that report, we commented that the different risks of
alcoholism associated with alleles at this site could be
explained by other relevant variation on the specific hap-
lotype at high frequency in eastern Asia. However, we
did not show that haplotyping of the ADH Class I poly-
morphisms resulted in an unusually high Fst but that
some individual sites in the gene cluster individually had
unusually high Fst values. One particular haplotype does
have a very large range of variation, but we do not
have an appropriate empiric distribution for Fst values
in multiallelic haplotype systems to show that it is un-
usually large. We showed that the “protective” allele,
ADH1B*47His, occurs primarily on a specific haplotype
in the Mediterranean and European populations studied
but occurs on a different haplotype in eastern Asia. We
concluded that the ADH1B*47His allele is likely to be
old, a conclusion Whitfield reiterates.
We do disagree with some of the conclusions Whit-
field reaches. He concludes that the effects of the
ADH1B*47His allele are not additive. However, be-
cause of the strong linkage disequilibrium (LD) across
the Class I gene cluster, Whitfield’s analysis showing
nonadditive allelic effects uses the ADH1B*47His allele
as a surrogate for the entire haplotype. Those analyses
do not provide sufficient evidence to limit the effect to
just that allele; some other variant on that haplotype
could be relevant. Taken together, the evidence that the
risk difference associated with this polymorphism is
not the same in Europe as it is in eastern Asia and
our demonstration that the haplotype containing the
ADH1B*47His allele is different in Europe from the one
in eastern Asia require us to focus on the entire haplotype
and not just on this one site. The nonadditive effects
cannot be attributed to the ADH1B*47His allele exclu-
sively, as Whitfield himself notes earlier in his introduc-
tory paragraph.
Whitfield repeats a common error when he says LD
will decrease over time, without noting all of the
assumptions involved in that deterministic result. In
regions of high disequilibrium caused by very low levels
of recombination, the effects of random genetic drift can
easily outweigh the deterministic expectation, as we have
demonstrated (Calafell et al. 2001). Modern humans
have existed outside of Africa for a relatively short time
and had small population sizes during much of that time.
Thus, drift associated with the expansion out of Africa
and diversification around the world can swamp any
factors like recombination that tend to reduce LD. Since
these ADH cluster genes are involved in alcohol metab-
olism, we of course have the additional complication of
determining to what extent natural selection may have
played a role in altering the frequency of particular hap-
lotypes in different geographical regions.
Letters to the Editor 1251
Finally, Whitfield implies it is important to determine
whether social factors or LD are responsible for the dif-
ferences in effects of ADH1B*47His in eastern Asia and
in Europe. Social factors can indeed be very important
in modifying risk associated with different genotypes.
For example, it will be difficult to determine the actual
risk associated with ADH variation in northern Africa
and the Middle East, since most populations in those
regions are Muslim and consumption of alcohol is pro-
scribed by their religion. However, we note that the rel-
evant “genetic” component is not strictly differences in
LD but differences in what haplotypes are present. A
site in the ADH cluster but not in LD with the ADH1B
Arg47His site could have an epistatic effect such that
only those chromosomes with particular alleles in cou-
pling account for the protective effect. Moreover, back-
ground genotype clearly differs at the population level
between eastern Asian populations and European pop-
ulations (e.g., Calafell et al. 1998) adding yet another
level of confounding on the path to understanding the
role of the ADH1B Arg47His polymorphism in risk of
alcoholism.
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Detecting Polymorphisms and Mutations in Candidate
Genes
To the Editor:
Currently, there is no consensus in the literature as to
the number and the nature of controls that should be
studied to distinguish between polymorphisms and dis-
ease-causing mutations (Bridge 1997). The quandary be-
comes particularly acute when we are trying to deter-
mine if a missense alteration in a candidate gene is
important (disease associated). How many control sam-
ples should be tested, and what other considerations
should go into the selection of controls? It is important
to consider and report the status, race or ethnic back-
ground, and sex (if appropriate) of controls. Further-
more, how many patients should be studied when one
is screening a gene for mutations? We have attempted
to address these concerns in this letter.
First, one needs to consider if the control subjects
could have the same disorder as the case subjects. Where
did the control subjects originate, and how were they
selected? The use of convenient control subjects (new-
born samples, unused diagnostic samples, etc.) may in-
advertently include individuals who are carriers or af-
fected. If one uses control subjects selected for a
particular study, they may or may not be appropriate
for a different study. When studying psychiatric disor-
ders, one needs to ensure that the controls do not have
undiagnosed problems. When studying late-onset dis-
eases, one needs to confirm that the control subjects are
past the age of onset.
Marchuk (1998) suggested typing controls from sim-
ilar racial, ethnic, and geographic backgrounds, since
allele frequencies can differ between groups. In the past,
ignoring this important tenet has caused some mutations
to be misclassified. The peripheral myelin protein 22
Thr118Met substitution was believed to be a mutation
in Charcot-Marie-Tooth disease, but was found to be a
Swedish polymorphism (Nelis et al. 1997). The fibrillin-
1 P1148A substitution was initially considered to be a
Marfan syndrome mutation in a mixed population of
patients, because it had not been found in white or Af-
rican American control subjects. However, it was later
found to be a polymorphism in Asians (Wang et al.
1997). The homeo box A1 A218G polymorphism was
reported to increase susceptibility to autism; however, it
was found to be more common in African Americans
than in whites (Collins et al., in press). Thus, one could
misinterpret a negative result if only a single racial or
ethnic group is utilized as a control population.
The sex of the control subjects is of obvious impor-
tance in testing for polymorphisms in X-linked genes.
